Rybrevant Faspro 57894-0514-01
Generic: Amivantamab And Hyaluronidase-Lpuj (human Recombinant)
- Manufacturer
- Janssen Biotech, Inc.
- Dosage Form
- Injection
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- December 19, 2025
- Listing Expires
- December 31, 2027
- Application
- BLA761433
Need to source Rybrevant Faspro? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Amivantamab | 2240 mg/14mL |
| Hyaluronidase (human Recombinant) | 28000 mg/14mL |
Drug Class
Endoglycosidase [EPC]Endoglycosidase [EPC]Glycoside Hydrolases [CS]
Selected Package
57894-0514-01Selected1 VIAL, SINGLE-DOSE in 1 CARTON (57894-514-01) / 14 mL in 1 VIAL, SINGLE-DOSE
External Resources